Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 42.92% is 37% above its 5-year average of 31.36%, near the high end of its 5-year range (21.95%–48.60%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.79% below its 12-month average of 43.26%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 42.92%.
DEBT TO ASSETS RATIO
42.92%
DEBT TO ASSETS RATIO AVG TTM
43.26%
DEBT TO ASSETS RATIO AVG 3Y
36.47%
DEBT TO ASSETS RATIO AVG 5Y
31.36%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-0.79%
CURRENT VS 3Y AVG
+17.67%
CURRENT VS 5Y AVG
+36.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.11%
median of 473 covered companies
CURRENT VS SECTOR MEDIAN
+38915.88%
vs the sector median at left
Astrana Health, Inc.
Market Cap
$1.83B
Debt to Assets Ratio
42.92%
TTM Avg
43.26%
3Y Avg
36.47%
5Y Avg
31.36%
Market Cap
$1.87B
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.11%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.78B
Debt to Assets Ratio
0.09%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.89B
Debt to Assets Ratio
0.04%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.76B
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.71B
Debt to Assets Ratio
0.44%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.96B
Debt to Assets Ratio
0.75%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Astrana Health, Inc. (ASTH) | $1.83B | 42.92% | 43.26% | 36.47% | 31.36% |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.87B | 0.03% | N/A | N/A | N/A |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | 0.11% | N/A | N/A | N/A |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.78B | 0.09% | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | 0.04% | N/A | N/A | N/A |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.76B | 0.26% | N/A | N/A | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.71B | 0.44% | N/A | N/A | N/A |
| Absci Corporation (ABSI)vs › | $1.95B | 0.01% | N/A | N/A | N/A |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.96B | 0.75% | N/A | N/A | N/A |
| Azenta, Inc. (AZTA)vs › | $1.97B | 0.03% | N/A | N/A | N/A |
Debt/Assets
42.9%
Debt/Equity
1.18
Current Ratio
1.23
Interest Coverage
1.6x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 42.92% |
| 2026-03-31 | 45.16% |
| 2025-12-31 | 48.59% |
| 2025-09-30 | 48.60% |
| 2025-06-30 | 31.03% |
| 2025-03-31 | 33.90% |
| 2024-12-31 | 34.82% |
| 2024-09-30 | 37.02% |
| 2024-06-30 | 37.96% |
| 2024-03-31 | 35.36% |
| 2023-12-31 | 34.39% |
| 2023-09-30 | 21.95% |
| 2023-06-30 | 22.42% |
| 2023-03-31 | 23.04% |
| 2022-12-31 | 23.74% |
| 2022-09-30 | 23.65% |
| 2022-06-30 | 23.47% |
| 2022-03-31 | 22.09% |
| 2021-12-31 | 23.17% |
| 2021-09-30 | 22.94% |
| 2021-06-30 | 22.43% |
